Star Lake Bioscience reports Q3 2025 operating data, profit up 49.9%

Star Lake Bioscience Inc. reported total operating revenue of 1,162,754.24 yuan for the first three quarters of 2025, with food and feed additives as the largest contributors. The company's total assets stood at 17,268,051,987.06 yuan. Profit attributable to shareholders for the first three quarters was 1,015,125,264.79 yuan, an increase of 49.90% year-over-year. This was despite a 6.46% decline in total profit to 1,258,860,719.04 yuan, due to lower product gross margins affecting total profit in the third quarter.

The company's outstanding external guarantees as of September 30, 2025, amounted to 308,109.75 yuan, representing 39.12% of its net assets. These guarantees are primarily for its wholly-owned and controlled subsidiaries. These subsidiaries' asset-liability ratios range from 27.72% to 85.35%, leading to a special risk reminder regarding guarantees for units with an asset-liability ratio exceeding 70%.

The guarantees align with the company's operational needs and were approved to support its subsidiaries' credit lines for 2025, with the board deeming the risk controllable.